Nisa Investment Advisors, LLC Iovance Biotherapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

$25.4 Billion
Q3 2025

A detailed history of Nisa Investment Advisors, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 3,254 shares of IOVA stock, worth $6,345. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,254

Previous 2,693 20.83%

Holding current value

$6,345

Previous $4,000 75.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	BUY	$1.7 - $3.97 $953 - $2,227	561 Added 20.83%	3,254 $7,000
Q2 2025 Jul 31, 2025	SELL	$1.66 - $3.61 $9,327 - $20,284	-5,619 Reduced 67.6%	2,693 $4,000
Q1 2025 Apr 30, 2025	BUY	$3.33 - $7.79 $1,255 - $2,936	377 Added 4.75%	8,312 $27,000
Q4 2024 Jan 17, 2025	SELL	$7.17 - $12.28 $2,681 - $4,592	-374 Reduced 4.5%	7,935 $58,000
Q3 2024 Oct 24, 2024	BUY	$7.28 - $11.9 $1,710 - $2,796	235 Added 2.91%	8,309 $78,000
Q2 2024 Jul 19, 2024	BUY	$7.78 - $14.19 $2,582 - $4,711	332 Added 4.29%	8,074 $64,000
Q1 2024 May 01, 2024	BUY	$7.59 - $17.47 $1,525 - $3,511	201 Added 2.67%	7,742 $114,000
Q4 2023 Jan 25, 2024	BUY	$3.3 - $8.89 $18,404 - $49,579	5,577 Added 283.96%	7,541 $61,000
Q3 2023 Nov 02, 2023	SELL	$4.44 - $8.79 $17,191 - $34,034	-3,872 Reduced 66.35%	1,964 $8,000
Q2 2023 Aug 11, 2023	BUY	$5.36 - $9.06 $10,532 - $17,802	1,965 Added 50.76%	5,836 $41,000
Q1 2023 May 02, 2023	BUY	$5.53 - $8.22 $11,032 - $16,398	1,995 Added 106.34%	3,871 $24,000
Q4 2022 Feb 02, 2023	SELL	$5.62 - $10.0 $25,638 - $45,620	-4,562 Reduced 70.86%	1,876 $12,000
Q3 2022 Nov 07, 2022	SELL	$9.53 - $13.11 $1,677 - $2,307	-176 Reduced 2.66%	6,438 $60,000
Q2 2022 Aug 03, 2022	BUY	$6.38 - $18.33 $39,492 - $113,462	6,190 Added 1459.91%	6,614 $73,000
Q4 2021 Feb 03, 2022	SELL	$16.55 - $27.63 $6,553 - $10,941	-396 Reduced 48.29%	424 $7,000
Q3 2021 Oct 18, 2021	SELL	$20.35 - $26.63 $112,922 - $147,769	-5,549 Reduced 87.13%	820 $20,000
Q4 2020 Jan 25, 2021	BUY	$28.04 - $50.26 $16,207 - $29,050	578 Added 9.98%	6,369 $296,000
Q3 2020 Oct 20, 2020	SELL	$27.75 - $36.3 $12,598 - $16,480	-454 Reduced 7.27%	5,791 $191,000
Q2 2020 Jul 27, 2020	BUY	$27.21 - $41.0 $146,498 - $220,744	5,384 Added 625.32%	6,245 $171,000
Q1 2020 Apr 17, 2020	BUY	$19.54 - $38.85 $3,126 - $6,216	160 Added 22.82%	861 $26,000
Q3 2019 Oct 17, 2019	SELL	$17.99 - $26.0 $4,479 - $6,474	-249 Reduced 26.21%	701 $13,000
Q1 2019 Apr 17, 2019	SELL	$8.41 - $11.26 $2,102 - $2,815	-250 Reduced 20.83%	950 $9,000
Q4 2018 Jan 17, 2019	BUY	$7.51 - $11.93 $5,181 - $8,231	690 Added 135.29%	1,200 $11,000
Q3 2018 Oct 16, 2018	SELL	$11.25 - $17.7 $2,137 - $3,363	-190 Reduced 27.14%	510 $6,000
Q1 2018 Apr 10, 2018	BUY	$8.1 - $19.5 $5,670 - $13,650	700 New	700 $12,000

Others Institutions Holding IOVA

# of Institutions

297

Shares Held

234M

Call Options Held

1.14M

Put Options Held

1.15M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $308M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Iovance Biotherapeutics, Inc. Transaction History